S
Prenatal diagnosis of pulmonary atresia is linked to improved oxygenation, but infants diagnosed with this condition postnatally will do just as well if they are identified and treated early, according to a new study in the May issue of the Archives of Disease in Childhood - Fetal and Neonatal Edition.
Aphrodite Tzifa, MD, of Guy's and St. Thomas' Hospital in London, UK, and colleagues sought to determine whether prenatal diagnosis of pulmonary atresia has any bearing on the clinical presentation and neonatal outcome among 37 newborns who received a prenatal diagnosis of pulmonary atresia and 21 who received their diagnosis after birth.
Infants diagnosed with pulmonary atresia postnatally were more hypoxic at birth than their counterparts diagnosed while in utero. Infants diagnosed postnatally presented on day 1 and prostaglandin E therapy was initiated within a median of 3 hours. As a result of such prompt diagnosis and treatment, postnatal diagnosis was not related to greater neonatal morbidity and mortality.
Tzifa A, Barker C, Tibby SM, et al. Prenatal diagnosis of pulmonary atresia: impact on clinical presentation and early outcome. Arch Dis Child- Fetal and Neonatal Edition. 2007;92:F199-F203.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More